Like every double-edged sword, ovarian cancer possessed improved sensitivity to DNA-damaging agents, namely, PARPis, by taking advantage of “synthetic lethality.” Synthetic lethality is the inability to tolerate the simultaneous loss of two important functions, literally the integrity of genome and DNA repair proteins, leading to cell death. The gene discussed is XRCC6P5; the disease is ovarian cancer.